Submit Deal

ENGENE INC

Summary

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 197 M

Avg. Deal Size£ 197 M

Market Context

Senior Management

Sort

Target: ENGENE INC

Bidder: FORBION EUROPEAN ACQUISITION CORP

14 Service Providers

19 Dealmakers

£ 196 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy